IQInvest research note
25 AUG 2026 · 15:34 ET
GILD
Gilead Sciences, Inc.
$148.10
$1.36 (+0.93%)up 0.93%
25 August 2026 · delayed 15+ min
D-
Cut-offs are the grader's own: 97+ for an A+, below 60 is an F.
Gilead Sciences, Inc. earns a D- on positive free cash flow and price well above 200-day SMA (strong uptrend) but negative profit margins and low ROE (<5%). Consider alternatives with better risk/reward profiles.
Adjusted for Moderate investors, Medium-term investors 4.0% suggested allocation Change these
IQ-GILD-20260825engine v1 · 7-category weighted scorecard